MedTrace Logo

Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With Inhibitors

NCT02554526 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2015-09-18

No results posted yet for this study

Summary

Using whole blood samples and plasma samples obtained from some hemophilia A patients with inhibitors, the investigators will perform the coagulation assessment in the co-presence of aPCC and factor VIII by comprehensive coagulation assays and flow chamber analysis under blood flow conditions.

Conditions

  • Hemophilia A With Inhibitor

Sponsors & Collaborators

  • Shire

    collaborator INDUSTRY

  • Nara Medical University

    lead OTHER

Principal Investigators

  • Midori Shima, MD, PhD · Nara Medical University

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-03-31
Completion
2017-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02554526 on ClinicalTrials.gov